Monoclonal antibodies are lab-engineered proteins that mimic the immune system’s ability to fight harmful pathogens. They bind to specific targets, such as viruses or cancer cells, to neutralize or flag them for destruction. Used in treatments for COVID-19, autoimmune diseases, and certain cancers, they benefit patients seeking targeted therapy with fewer side effects than traditional drugs.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends